Abstract
A total of 113 clinical Campylobacter strains (105 C. jejuni, 7 C. coli, 1 C. lari) were collected between 2006 and 2008 and tested for antimicrobial susceptibility to erythromycin, ciprofloxacin, doxycycline and meropenem. Of all the Campylobacter isolates, 52.2\% were resistant to ciprofloxacin and 38.0\% to doxycycline. None of them was resistant to erythromycin or meropenem. However, 51.3\% of all Campylobacter isolates were intermediate susceptible to erythromycin (minimum inhibitory concentration 1-4 mg/l). These data confirm the value of macrolides as the drugs of choice for the treatment of severe Campylobacter infections.
- 80
- adolescent,
- adult
- adult,
- aged,
- agents,
- ag_horn
- and
- bacterial,
- campylobacter
- campylobacter,
- child,
- drug
- female,
- germany,
- hospitals,
- humans,
- infant,
- infections,
- male,
- microbial
- middle
- newborn,
- over,
- preschool,
- resistance,
- sensitivity
- tests,
- university,
- young
- {anti-bacterial}
Users
Please
log in to take part in the discussion (add own reviews or comments).